跳至主要内容
临床试验/NCT03320447
NCT03320447已完成1 期

Long-term Efficacy of Ablative Fractional Laser-assisted Photodynamic Therapy for Treatment of Lower Extremity Bowen's Disease: A Prospective, Randomized, Controlled Trial With 5-year Follow up

Dong-A University0 个研究点目标入组 60 人开始时间: 2011年10月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
60
主要终点
Difference of short-term complete response (CR) rate between AFL-PDT and MAL-PDT

研究概览

简要总结

Er:YAG ablative fractional laser-assisted methyl aminolevulinate photodynamic therapy (AFL-PDT) has shown significantly higher efficacy and a lower recurrence rate at 12 months than methyl aminolevulinate photodynamic therapy (MAL-PDT) for treatment of Bowen's disease (BD). However, long-term follow up data are not available.

详细描述

To compare the long-term efficacy and recurrence rates of AFL-PDT and standard MAL-PDT for the treatment of lower extremity BD.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
42 Years 至 89 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • •Patients aged 18 years or more who diagnosed as bowen's disease

排除标准

  • pregnancy or lactation
  • active systemic infectious disease
  • other inflammatory, infectious, or neoplastic skin diseases in the treated area
  • allergy to MAL,other topical photosensitizers, or excipients of the cream
  • history of photosensitivity
  • use of immunosuppressive or photosensitizing drugs
  • participation in any other investigational study in the preceding 30 days
  • history or indicators of poor compliance
  • Histological findings of acantholysis, desmoplasia, perineural or lymphovascular invasion, and echographic features of regional lymph node metastasis were the disease-specific exclusion criteria

研究组 & 干预措施

MAL-PDT

Experimental

Patients were randomly assigned to receive either AFL-PDT or MAL-PDT in a 1:1 ratio. As result, the patients were randomized to treatment with AFL-PDT or MAL-PDT

干预措施: methyl-aminolevulinate application (Drug)

MAL-PDT

Experimental

Patients were randomly assigned to receive either AFL-PDT or MAL-PDT in a 1:1 ratio. As result, the patients were randomized to treatment with AFL-PDT or MAL-PDT

干预措施: Illuminating using red light-emitting diode lamps (Device)

AFL-PDT

Experimental

Patients were randomly assigned to receive either AFL-PDT or MAL-PDT in a 1:1 ratio. As result, the patients were randomized to treatment with AFL-PDT or MAL-PDT

干预措施: lidocaine-prilocaine 5% cream application (Drug)

AFL-PDT

Experimental

Patients were randomly assigned to receive either AFL-PDT or MAL-PDT in a 1:1 ratio. As result, the patients were randomized to treatment with AFL-PDT or MAL-PDT

干预措施: methyl-aminolevulinate application (Drug)

AFL-PDT

Experimental

Patients were randomly assigned to receive either AFL-PDT or MAL-PDT in a 1:1 ratio. As result, the patients were randomized to treatment with AFL-PDT or MAL-PDT

干预措施: Illuminating using red light-emitting diode lamps (Device)

结局指标

主要结局

Difference of short-term complete response (CR) rate between AFL-PDT and MAL-PDT

时间窗: Short-term CR rate was evaluated at 3 months

The response was classified as either complete response (complete disappearance of the lesion) or incomplete response (incomplete disappearance of the lesion)

Difference of long-term complete response (CR) rate between AFL-PDT and MAL-PDT

时间窗: Long-term CR rate was evaluated at 60 months

The response was classified as either complete response (complete disappearance of the lesion) or incomplete response (incomplete disappearance of the lesion)

Difference of long-term recurrence rate between AFL-PDT and MAL-PDT at 60 months

时间窗: Recurrent rate was evaluated at 60 months

In all cases of complete response, the patients were reviewed at 60 months to check for recurrence. Post-therapy punch biopsies were performed when there was doubt concerning incomplete-response and clinical recurrence

次要结局

  • Difference of the cosmetic outcome between AFL-PDT and MAL-PDT(Cosmetic outcome was assessed by each investigator for all lesions that achieved a complete response at 60 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Song Ki-Hoon

Associate professor

Dong-A University

相似试验